Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Arterial Hypertension

Explore clinical trials studying Pulmonary Arterial Hypertension. Study availability and eligibility vary by location and protocol.

466 public trials 67 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Arterial Hypertension trial results

Completed

Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension

NCT00660179

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Pulmonary Specialists Pheonix, Arizona, United States
  • GLVA Healthcare Center Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
View all 153 locations
View Trial Details
Completed

Assessmet of Patients With PAH Right Ventricular Volume

NCT01557582

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details
Completed

Tyvaso Dosing and Titration Evaluation: TyTRATE Registry

NCT01799473

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • The Regents of the University of California La Jolla, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Southern California Permanente Pasadena, California, United States
  • Central Coast Chest Consultants San Luis Obispo, California, United States
View all 52 locations
View Trial Details
Completed

Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial Hypertension

NCT00477269

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • Novartis Investigative Site Los Angeles, California, United States
  • Novartis investigative site Newark, New Jersey, United States
  • Novartis Investigative Site New York, United States
  • Novartis Investigative Site Graz, Austria
View all 13 locations
View Trial Details
Completed

Epoprostenol for Injection (EFI/ACT-385781A) - Pulmonary Arterial Hypertension

NCT01431716

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • UZ Gasthuisberg Leuven, Belgium
  • University Health Network, Toronto TGH - 10 EN - 220 Toronto, Ontario, Canada
  • Sir Mortimer B Davis Jewish General Hospital Montreal, Quebec, Canada
  • Centre Hospitalier Universitaire Caen, France
View Trial Details

Related conditions